Consultant and
Facilities Finder

Current NHS consultant posts held

Chelsea and Westminster Hosp London

Research interests

Nutritional aspects of management of inflammatory bowel disease. Gastrointestinal consequences of food allergy.

Publications

Fell JM. Update of the management of inflammatory bowel disease. Arch Dis Child. 2012; 97: 78-83

Fell JM. Management of Adolescents with Inflammatory Bowel Disease
In: Inflammatory Bowel Disease - an evidence-based guide. Edited: Hart AL, Ng S tfm publishing Ltd ISBN: 978 1 903378 82 3; 2012


Fell JME. Recognition, assessment and management of eosinophilic oesophagitis. Arch Dis Child 2013; 98(9): 702-6

Fell JM, Rafeeq M, Spray C, Crooke K, Russell RK. Management of Ulcerative Colitis. Arch Dis Child 2016; 101: 469-474


Thangarajah D, Hyde M, Konteti V, Santhakumaran S, Frost G, Fell J. Systematic review: body composition in children with inflammatory bowel disease. Aliment Pharmacol Ther. 2015; 42: 142-157

Vora R, Bernardo D, Durant L, Reddi D, Hart A, Fell J, Al-Hassi H, Knight S. Age-related alterations in blood and colonic dendritic cell properties. Oncotarget Journal, 2016; in press

Aloi M, Birimberg-Schwartz L, Buderus S, Hojsak I, Fell JM, Bronsky J, Veereman G, Koletzko S, Shaoul R, Miele E, Turner D, Russell RK.
Treatment options and outcomes of pediatric inflammatory bowel disease unclassified (IBDU) compared to other IBD subtypes: a retrospective multicentre study from the IBD Porto group of ESPGHAN. Inflamm Bowel Dis 2016; 22: 1376-1383

Rampton D, Goodhand J, Joshi N, Karim A-B, Koodun Y, Barakat F, Macken L, Ward D, Iqbal T, Epstein J, Fell J, Sanderson I. Response of iron deficiency anaemia to oral iron in adolescents and adults with inflammatory bowel disease: relation to disease activity, quality of life and serum hepcidin. J Crohn’s Colitis 2016 in press

Minshall E, Patel P, Francis N, Hansel T, Warner JO, Boyle RJ, Fell J, Epstein J. Local chemokine profiling in eosinophilic esophagitis: the Synthetic Absorptive 1 Matrix test. Ped All Immunol 2016 in press


Hyams JS, Dubinsky MC, Baldassano RN, Colletti RB, Cucchiara S, Escher J, Faubion W, Fell J, Gold BD, Griffiths A, Koletzko S, Kugathasan S, Markowitz J, Ruemmele FM, Veereman G, Winter H, Masel N, Shin CR, Tang KL, Thayu M. Infliximab is not Associated with an Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric IBD. Gastroenterology 2017 in press